Recent Articles

• Discover the StormX Fat-Tire E-Bike: A Canadian Marvel
• DefenseWireNews Unveils New Insights for Industry Innovators
• Mevolaxy Achieves Unprecedented Success with Record Payouts
• Mevolaxy Transitions to MEV Staking for Enhanced Returns
• Investors Urged to Act After Lineage, Inc. Share Misconduct
• AAR Corp Plans $150 Million Senior Notes Offering for 2029
• Inspire Medical Systems Launches $200 Million Share Buyback Plan
• Future FinTech Group Moves to Expand with VASP License Application
• ArriVent BioPharma: Insights into Q2 2025 Financials
• Greenridge Exploration Unveils Exciting Drilling Plans for Uranium
• Transforming Sales Forecasting with AI: Insights from MarketsandMarkets
• Madrigal Pharmaceuticals Joins Canaccord Genuity Growth Conference
• GBT Technologies Rebrands to Wertheim, Welcomes New Leadership
• GBT Technologies Transforms into Wertheim & Company with New Leadership
• vTv Therapeutics Advances Cadisegliatin with New Patent Approval
• Enphase Energy Launches Innovative IQ Battery 5P for Australia
• JDE Peet's Accelerates Share Buyback to Boost Value
• XWELL, Inc. Celebrates Compliance with Nasdaq Standards
• Schouw & Co.'s Share Buy-Back Updates Through August 2025
• PodcastOne Reports Q1 Financial Results and Investor Webcast
• Safran DSI Powers AstroForge's Asteroid Mining Mission
• LiveOne to Reveal Q1 Fiscal 2026 Results and Webcast Info
• WTW Hires Nicholas Carbo as Senior Director for ICT Services
• U Power and UNEX EV Partner with Didi to Revolutionize EVs
• Gabelli Funds Prepares for Aerospace & Defense Symposium 2025
• Paramount and TKO Strike Historic Deal for UFC Broadcast Rights
• 4DMT Sees Promising Growth and Milestones in Q2 2025
• Cache Public Schools Launches Eco-Friendly Electric Buses
• Helius Minerals Advances Serra Pelada Gold-PGM Project Progress
• vTv Therapeutics Secures Patent for Cadisegliatin Advancements
• Theriva Biologics: Q2 Results and Future Milestones for Cancer Therapies
• Analysts Weigh In: Investment Opportunities and Stock Ratings
• C3.ai's Recent Downshift: Analysts Adjust Price Targets
• Health Care Stocks to Watch: Big Upside Potential This Month
• Top Wall Street Analyst Stock Recommendations This Week
• Lincoln Educational Services Boosts Revenue and Student Growth
• Blue Gold's Strategic Acquisition: A Smart Move for Investors
• Upexi, Inc. Shareholder Investigation Highlights Board Duties
• Evaxion Preparing for Exciting Business Update on Upcoming Results
• 180 Life Sciences Raises $156 Million in Convertible Notes Sale
• OverActive Media Plans Upcoming Earnings Call for Q2 2025
• Qubitera Holdings Unveils Ambitious Global Health Tech Plans
• Ben Hays Takes Over as Director of YPTC's Phoenix Office
• Jack Henry Enhances Digital Banking Experience with New Tools
• Catheter Precision's Impressive Q2 Growth and Innovations
• Trump Media Enhances Bitcoin ETF Initiative for Future Growth
• Innovative AI Enhances Recruiting with Immersive Job Previews
• CervoMed's Progress in Clinical Trials and Financial Insights
• Hyperlink InfoSystem Set to Showcase Innovations at GITEX 2025
• Fundamental Global Inc. Transitions to New Ticker Symbols